ElevateBio | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Company Directory for ElevateBio

ElevateBio

Overview

ElevateBio is a biotechnology holding company based in Cambridge, Massachusetts, founded in late 2017. The company focuses on the development, manufacturing, and delivery of cell and gene therapies through a fully integrated ecosystem. This includes R&D platforms, cGMP manufacturing, and drug development, all aimed at addressing challenges in the cell and gene therapy landscape.

Operating as both a contract development and manufacturing organization (CDMO) and an investment holding company, ElevateBio's BaseCamp facility in Waltham, Massachusetts, is a centralized 100,000 square-foot space supporting high-scale production of experimental therapies. The company develops a diverse portfolio of therapies, including allogeneic CAR-T cells and in vivo gene editing solutions, while collaborating with academic researchers and biopharma leaders to create new companies and advance innovative treatments.

Basic Information

Industry research
Founded 2017
Revenue 120M
Headquarters 200 Smith St, Waltham, Massachusetts 02451, United States

Contact Details

Key Focus Areas & Initiatives

  • Cell therapy
  • Gene therapy
  • Biotechnology research
  • Cell therapy platforms
  • Ex vivo cell therapies
  • Analytical development
  • Regenerative medicines
  • Cell & gene therapy platforms
  • Ex vivo therapies
  • Therapeutic design & approaches
  • Genetic medicine support
  • Lipid nanoparticle delivery
  • RNA, protein & vector engineering
  • Apheresis
  • Process development
  • Innovation
  • Biotech manufacturing
  • Biopharmaceutical support
  • CRISPR
  • Regenerative medicine
  • Biotech innovation
  • Gene therapy platforms
  • RNA therapeutics manufacturing
  • Therapeutic modalities development
  • Gene editing tools
  • Life sciences
  • Cell therapy manufacturing
  • RNA therapeutics
  • Genetic medicines platform
  • B2B
  • Therapeutic design
  • Genetic medicines ecosystem
  • Genetic medicine innovation
  • Therapeutic development platforms
  • Gene therapy scale-up
  • Gene therapy manufacturing
  • Cell & gene therapy support
  • Lipid nanoparticles
  • Gene editing platforms
  • Pharmaceuticals
  • Consulting
  • Gene editing
  • Cell & gene therapy innovation
  • Medical research
  • Viral vector platforms
  • Process automation
  • End-to-end capabilities
  • Viral & non-viral platforms
  • Funding
  • Cell therapy support
  • Viral vector production
  • Cell manufacturing
  • Cell & gene therapy partnerships
  • Gene editing patents
  • Therapeutic innovation
  • Platform technologies
  • Research and development in the physical, engineering, and life sciences
  • Viral delivery platforms
  • Gene editing tool development
  • Cell therapy enabling technologies
  • Gene editing technologies
  • Analytical services and quality
  • Viral & non-viral delivery technologies
  • Viral vector optimization
  • Genetic medicines
  • In vivo gene therapies
  • Therapeutic discovery
  • Therapeutic modalities
  • Manufacturing scale-up
  • Genetic medicine ecosystem
  • RNA engineering
  • Cell therapy process development
  • Biomanufacturing
  • Viral vector manufacturing
  • Viral & non-viral delivery platforms
  • Biotech ecosystem
  • Therapeutic development
  • cGMP manufacturing
  • Genetic engineering
  • Non-viral delivery platforms
  • RNA & protein engineering
  • Biomanufacturing automation
  • Gene editing innovation
  • Biomanufacturing capabilities
  • Pharmaceutical
  • Automation
  • Biotech manufacturing support
  • Gene therapy development
  • Therapeutic delivery
  • Biotechnology
  • Gene editing toolboxes
  • CRISPR gene editing
  • Molecular engineering
  • CRISPR technology
  • Vector engineering
  • Clinical manufacturing
  • In vivo therapies
  • Analytical services
  • Quality control
  • Novel therapeutics
  • Biopharmaceutical partnerships
  • Immunotherapy
  • Scalable manufacturing
  • Viral delivery systems
  • Non-viral delivery systems
  • Biotechnology innovations
  • Regenerative cellular therapies
  • Partnering strategies
  • Biotech collaboration
  • Advanced therapeutics
  • Harnessing human cells
  • Genetic medicine
  • Integrated manufacturing model
  • Full-spectrum gene editing
  • Transformative therapies
  • Biopharma integration
  • Scientific advancements
  • Precision medicine
  • Therapeutic pipelines
  • Academic partnerships
  • Industry partnerships
  • Clinical research
  • Healthcare innovation
  • Drug development
  • Therapeutic approaches
  • Health care
  • Health, wellness & fitness
  • Hospital & health care
  • Mechanical or industrial engineering

Technologies Used

  • .NET
  • AC500 PLC
  • ANGEL LMS
  • AVEVA PDMS
  • AWS Batch
  • Amazon EC2
  • Amazon S3
  • Asana
  • BASE
  • Basecamp
  • Basis
  • CET
  • Gem
  • Google VPC Service Controls
  • Hubspot
  • IBM SPSS Modeler
  • IQMS
  • Inductive Automation Ignition
  • LabWare LIMS
  • NDN
  • Olo
  • Python
  • R
  • Remote
  • SAP
  • ServiceNow
  • Siemens Desigo
  • Siemens SIMATIC HMI (Human Machine Interface)
  • Siemens SIMATIC S7
  • Siemens SIMATIC SCADA
  • Tor
  • Veeva Systems
  • Veeva Vault
  • Viewpoint
  • Wider Planet
  • eMaint CMMS

Read more